The global, regional, and national burden of cancer among adolescents and young adults in 204 countries and territories, 1990-2019: a population-based study

被引:45
作者
Wen, Yi Feng [1 ]
Chen, Meng Xuan [1 ]
Yin, Guosheng [2 ]
Lin, Ruitao [3 ]
Zhong, Yu Jie [4 ]
Dong, Qian Qian [1 ]
Wong, Hai Ming [5 ]
机构
[1] Xi An Jiao Tong Univ, Coll Stomatol, Key Lab Shaanxi Prov Craniofacial Precis Med Res, Xian, Peoples R China
[2] Univ Hong Kong, Dept Stat & Actuarial Sci, Pok Fu Lam, Hong Kong, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Xi An Jiao Tong Univ, Dept Pulm & Crit Care Med, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China
[5] Univ Hong Kong, Fac Dent, Paediat Dent & Orthodont, Pok Fu Lam, 34 Hosp Rd, Hong Kong, Peoples R China
关键词
Adolescents and young adults; Global burden of disease study; Cancer; Prevalence; Mortality; CHILDREN;
D O I
10.1186/s13045-021-01093-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Accurate appraisal of burden of adolescents and young adults (AYAs) cancers is crucial to informing resource allocation and policy making. We report on the latest estimates of burden of AYA cancers in 204 countries and territories between 1990 and 2019 in association with socio-demographic index (SDI). Patients and methods Estimates from the Global Burden of Disease study 2019 were used to analyse incidence, mortality, and disability-adjusted life years (DALYs) due to AYA cancers at global, regional, and national levels by sex. Association between AYA cancer burden and SDI were investigated. Burdens of AYA cancers were contextualized in comparison with childhood and older adult cancers. All estimates are reported as counts and age-standardized rates per 100,000 person-years. Results In 2019, there were 1.2 million incident cases, 0.4 million deaths, and 23.5 million DALYs due to AYA cancers globally. The highest age-standardized incidence rate occurred in Western Europe (75.3 [Females] and 67.4 [Males] per 100,000 person-years). Age-standardized death (23.2 [Females] and 13.9 [Males] per 100,000 person-years) and DALY (1328.3 [Females] and 1059.2 [Males] per 100,000 person-years) rates were highest in Oceania. Increasing SDI was associated with a higher age-standardized incidence rate. An inverted U-shaped association was identified between SDI and death and DALY rates. AYA cancers collectively is the second leading cause of non-communicable diseases-related deaths globally in 2019. DALYs of AYA cancers ranked the second globally and the first in low and low-middle SDI locations when compared with that of childhood and older adult cancers. Conclusion The global burden of AYA cancers is substantial and disproportionally affect populations in limited-resource settings. Capacity building for AYA cancers is essential in promoting equity and population health worldwide.
引用
收藏
页数:14
相关论文
共 37 条
[1]  
Adolescent and Young Adult Oncology Progress Review Group, CLOS GAP RES CAR IMP
[2]  
[Anonymous], GLOBAL BURDEN DIS ST
[3]   Classification schemes for tumors diagnosed in adolescents and young adults [J].
Barr, RD ;
Holowaty, EJ ;
Birch, JM .
CANCER, 2006, 106 (07) :1425-1430
[4]   Cancer in Adolescents and Young Adults A Narrative Review of the Current Status and a View of the Future [J].
Barr, Ronald D. ;
Ferrari, Andrea ;
Ries, Lynn ;
Whelan, Jeremy ;
Bleyer, W. Archie .
JAMA PEDIATRICS, 2016, 170 (05) :495-501
[5]   AIDS-Related cancer and severity of immunosuppression in persons with AIDS [J].
Biggar, Robert J. ;
Chaturvedi, Anil K. ;
Goedert, James J. ;
Engels, Eric A. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12) :962-972
[6]   The distinctive biology of cancer in adolescents and young adults [J].
Bleyer, Archie ;
Barr, Ronald ;
Hayes-Lattin, Brandon ;
Thomas, David ;
Ellis, Chad ;
Anderson, Barry .
NATURE REVIEWS CANCER, 2008, 8 (04) :288-298
[7]   National cancer clinical trials: Children have equal access; Adolescents do not [J].
Bleyer, WA ;
Tejeda, H ;
Murphy, SB ;
Robison, LL ;
Ross, JA ;
Pollock, BH ;
Severson, RK ;
Brawley, OW ;
Smith, MA ;
Ungerleider, RS .
JOURNAL OF ADOLESCENT HEALTH, 1997, 21 (06) :366-373
[8]  
Boyle P, 1991, IARC Sci Publ, P126
[9]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[10]   Treatment of Chronic Lymphocytic Leukemia [J].
Burger, Jan A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05) :460-473